Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa

Collins Iwuji, Rujeko Samanthia Chimukuche, Thembelihle Zuma, Melanie Plazy, Joseph Larmarange, Joanna Orne-Gliemann, Mark Siedner, Maryam Shahmanesh, Janet Seeley, Collins Iwuji, Rujeko Samanthia Chimukuche, Thembelihle Zuma, Melanie Plazy, Joseph Larmarange, Joanna Orne-Gliemann, Mark Siedner, Maryam Shahmanesh, Janet Seeley

Abstract

Introduction: Antiretroviral therapy (ART) has revolutionised the care of HIV-positive individuals resulting in marked decreases in morbidity and mortality, and markedly reduced transmission to sexual partners. However, these benefits can only be realised if individuals are aware of their HIV-positive status, initiated and retained on suppressive lifelong ART. Framed using the socio-ecological model, the present study explores factors contributing to poor ART uptake among community members despite high acceptance of HIV-testing within a Treatment as Prevention (TasP) trial. In this paper we identify barriers and facilitators to treatment across different levels of the socio-ecological framework covering individual, community and health system components.

Methods: This research was embedded within a cluster-randomised trial (ClinicalTrials.gov, number NCT01509508) of HIV treatment as Prevention in rural KwaZulu-Natal, South Africa. Data were collected between January 2013 and July 2014 from resident community members. Ten participants contributed to repeat in-depth interviews whilst 42 participants took part in repeat focus group discussions. Data from individual interviews and focus group discussions were triangulated using community walks to give insights into community members' perception of the barriers and facilitators of ART uptake. We used thematic analysis guided by a socio-ecological framework to analyse participants' narratives from both individual interviews and focus group discussions.

Results: Barriers and facilitators operating at the individual, community and health system levels influence ART uptake. Stigma was an over-arching barrier, across all three levels and expressed variably as fear of HIV disclosure, concerns about segregated HIV clinical services and negative community religious perceptions. Other barriers were individual (substance misuse, fear of ART side effects), community (alternative health beliefs). Facilitators cited by participants included individual (expectations of improved health and longer life expectancy following ART, single tablet regimens), community (availability of ART in the community through mobile trial facilities) and health system factors (fast and efficient service provided by friendly staff).

Discussion: We identified multiple barriers to achieving universal ART uptake. To enhance uptake in HIV care services, and achieve the full benefits of ART requires interventions that tackle persistent HIV stigma, and offer people with HIV respectful, convenient and efficient services. These interventions require evaluation in appropriately designed studies.

Conflict of interest statement

I have updated the competing interest statement in the text of the manuscript. Revised text below I have read the journal's policy and the authors of this manuscript have the following competing interests: CI received research grants, honoraria for consulting services and conference attendance support from Gilead Sciences. All other authors declare that they have no conflicts of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1. Barriers and facilitators to ART…
Fig 1. Barriers and facilitators to ART uptake and viral suppression using the socio-ecological model.

References

    1. Group ISS, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373(9):795–807. 10.1056/NEJMoa1506816
    1. Group TAS, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015;373(9):808–22. 10.1056/NEJMoa1507198
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. 10.1056/NEJMoa1105243
    1. Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016;316(2):171–81. 10.1001/jama.2016.5148
    1. Makhema MJ, Wirth K, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, et al. Impact of prevention and treatment interventions on population HIV incidence: Primary results of the community-randomized Ya Tsie Botswana prevention project. 22nd International AIDS Conference 23–27 July 2018; Amsterdam, 2018.
    1. Iwuji CC, McGrath N, de Oliveira T, Porter K, Pillay D, Fisher M, et al. The Art of HIV Elimination: Past and Present Science. J AIDS Clin Res. 2015;6.
    1. World Health Organisation. Universal Health Coverage (UHC) 2019. [cited 2019, 30 June]. Available from: .
    1. Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H, et al. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa. J Int AIDS Soc. 2018;21(1).
    1. Havlir D, Charlebois E, Balzer L, Clark T, Kwarisiima D, Ayieko J, et al. SEARCH community cluster randomized study of HIV “test and treat” using multi- disease approach and streamlined care in rural Uganda and Kenya. 22ND International AIDS Conference; 23–27 July 2018; Amsterdam, Netherlands2018.
    1. Abdool Karim SS. HIV-1 Epidemic Control—Insights from Test-and-Treat Trials. The New England journal of medicine. 2019;381(3):286–8. 10.1056/NEJMe1907279
    1. Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2018;5(3):e116–e25. 10.1016/S2352-3018(17)30205-9
    1. Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, et al. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLoS Med. 2016;13(8):e1002107 10.1371/journal.pmed.1002107
    1. Plazy M, Farouki KE, Iwuji C, Okesola N, Orne-Gliemann J, Larmarange J, et al. Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster-randomized trial in rural South Africa. J Int AIDS Soc. 2016;19(1):20913 10.7448/IAS.19.1.20913
    1. Bajunirwe F, Tumwebaze F, Akakimpa D, Kityo C, Mugyenyi P, Abongomera G. Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services-A Qualitative Study in 19 Ugandan Districts. Biomed Res Int. 2018;2018:9619684 10.1155/2018/9619684
    1. Schwitters A, Lederer P, Zilversmit L, Gudo PS, Ramiro I, Cumba L, et al. Barriers to health care in rural Mozambique: a rapid ethnographic assessment of planned mobile health clinics for ART. Glob Health Sci Pract. 2015;3(1):109–16. 10.9745/GHSP-D-14-00145
    1. Musheke M, Bond V, Merten S. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study. AIDS Patient Care STDS. 2013;27(4):231–41. 10.1089/apc.2012.0341
    1. Kawuma R, Seeley J, Mupambireyi Z, Cowan F, Bernays S, Team RT. “Treatment is not yet necessary”: delays in seeking access to HIV treatment in Uganda and Zimbabwe. African Journal of AIDS Research. 2018;17(3):217–25. 10.2989/16085906.2018.1490785
    1. Bor J, Ahmed S, Fox MP, Rosen S, Meyer-Rath G, Katz IT, et al. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study. PLoS One. 2017;12(6):e0178249 10.1371/journal.pone.0178249
    1. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15(2):17383 10.7448/IAS.15.2.17383
    1. Treves-Kagan S, Steward WT, Ntswane L, Haller R, Gilvydis JM, Gulati H, et al. Why increasing availability of ART is not enough: a rapid, community-based study on how HIV-related stigma impacts engagement to care in rural South Africa. BMC Public Health. 2016;16:87 10.1186/s12889-016-2753-2
    1. Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(3 Suppl 2):18734.
    1. Bond V, Ngwenya F, Thomas A, Simuyaba M, Hoddinott G, Fidler S, et al. Spinning plates: livelihood mobility, household responsibility and anti-retroviral treatment in an urban Zambian community during the HPTN 071 (PopART) study. J Int AIDS Soc. 2018;21 Suppl 4:e25117.
    1. Seeley J, Bond V, Yang B, Floyd S, MacLeod D, Viljoen L, et al. Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa. AIDS Behav. 2019;23(4):929–46. 10.1007/s10461-018-2335-7
    1. Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED, et al. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018;13(8):e0202990 10.1371/journal.pone.0202990
    1. Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, et al. Effect of Universal Testing and Treatment on HIV Incidence—HPTN 071 (PopART). The New England journal of medicine. 2019;381(3):207–18. 10.1056/NEJMoa1814556
    1. Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, et al. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. The New England journal of medicine. 2019;381(3):219–29. 10.1056/NEJMoa1809866
    1. Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, et al. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana. The New England journal of medicine. 2019;381(3):230–42. 10.1056/NEJMoa1812281
    1. Latkin CA, German D, Vlahov D, Galea S. Neighborhoods and HIV: a social ecological approach to prevention and care. American Psychologist. 2013;68(4):210 10.1037/a0032704
    1. Zuma T, Wight D, Rochat T, Moshabela M. Navigating Multiple Sources of Healing in the Context of HIV/AIDS and Wide Availability of Antiretroviral Treatment: A Qualitative Study of Community Participants' Perceptions and Experiences in Rural South Africa. Front Public Health. 2018;6:73 10.3389/fpubh.2018.00073
    1. Yakob B, Ncama BP. A socio-ecological perspective of access to and acceptability of HIV/AIDS treatment and care services: a qualitative case study research. BMC Public Health. 2016;16(1):155.
    1. Camlin CS, Hosegood V, Newell ML, McGrath N, Barnighausen T, Snow RC. Gender, migration and HIV in rural KwaZulu-Natal, South Africa. PLoS One. 2010;5(7):e11539 10.1371/journal.pone.0011539
    1. Hosegood V, McGrath N, Moultrie T. Dispensing with marriage: Marital and partnership trends in rural KwaZulu-Natal, South Africa 2000–2006. Demogr Res. 2009;20:279–312. 10.4054/DemRes.2009.20.13
    1. Chimbindi N, Mthiyane N, Birdthistle I, Floyd S, McGrath N, Pillay D, et al. Persistently high incidence of HIV and poor service uptake in adolescent girls and young women in rural KwaZulu-Natal, South Africa prior to DREAMS. PLoS One. 2018;13(10):e0203193 10.1371/journal.pone.0203193
    1. Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Bärnighausen T, et al. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC public health. 2015;15(1):1.
    1. Kitzinger J. Qualitative research. Introducing focus groups. BMJ: British medical journal. 1995;311(7000):299 10.1136/bmj.311.7000.299
    1. Petty NJ, Thomson OP, Stew G. Ready for a paradigm shift? Part 2: Introducing qualitative research methodologies and methods. Manual therapy. 2012;17(5):378–84. 10.1016/j.math.2012.03.004
    1. Ritchie J, Lewis J, Nicholls CM, Ormston R. Qualitative research practice: A guide for social science students and researchers: sage; 2013.
    1. Musante K, DeWalt BR. Participant observation: A guide for fieldworkers: Rowman Altamira; 2010.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 2006;3(2):77–101.
    1. Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment—a study protocol for a cluster randomised trial. Trials. 2014;15:57 10.1186/1745-6215-15-57
    1. Bond V, Nomsenge S, Mwamba M, Ziba D, Birch A, Mubekapi-Musadaidzwa C, et al. "Being seen" at the clinic: Zambian and South African health worker reflections on the relationship between health facility spatial organisation and items and HIV stigma in 21 health facilities, the HPTN 071 (PopART) study. Health Place. 2019;55:87–99. 10.1016/j.healthplace.2018.11.006
    1. Chamie G, Clark TD, Kabami J, Kadede K, Ssemmondo E, Steinfeld R, et al. A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. Lancet HIV. 2016;3(3):e111–9. 10.1016/S2352-3018(15)00251-9
    1. Petersen M, Balzer L, Kwarsiima D, Sang N, Chamie G, Ayieko J, et al. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa. JAMA. 2017;317(21):2196–206. 10.1001/jama.2017.5705
    1. Grimsrud A, Sharp J, Kalombo C, Bekker LG, Myer L. Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa. J Int AIDS Soc. 2015;18:19984 10.7448/IAS.18.1.19984
    1. Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, Mantangana N, et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One. 2013;8(2):e56088 10.1371/journal.pone.0056088
    1. Pantelic M, Cluver L, Boyes M, Toska E, Kuo C, Moshabela M. Medical pluralism predicts non-ART use among parents in need of ART: a community survey in KwaZulu-Natal, South Africa. AIDS Behav. 2015;19(1):137–44. 10.1007/s10461-014-0852-6
    1. Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:63 10.1186/1471-2458-8-63
    1. Zou J, Yamanaka Y, John M, Watt M, Ostermann J, Thielman N. Religion and HIV in Tanzania: influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes. BMC Public Health. 2009;9:75 10.1186/1471-2458-9-75
    1. Szaflarski M. Spirituality and Religion amongst HIV-Infected Individuals. Curr HIV/AIDS Rep 2013;10(4):324–32. 10.1007/s11904-013-0175-7
    1. Probst C, Parry CDH, Rehm J. HIV/AIDS mortality attributable to alcohol use in South Africa: a comparative risk assessment by socioeconomic status. BMJ Open. 2018;8(2):e017955 10.1136/bmjopen-2017-017955
    1. Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, et al. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med. 2017.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅